Skip to main content
Signal8

Electromed, Inc. (ELMD)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Sector: Electromedical & Electrotherapeutic Apparatus

Industry: Medical - Devices

Electromed, Inc. logo

Electromed, Inc.

NYSE:ELMDHealthcare
+0.15%$26.66
Mkt Cap$223.04M
Float6.59M
O/S8.37M
Inst Own56.5%
SI3.0%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$223.04M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership56.50%

based on 8.37M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE American
CountryUSUS
IPO DateAug 13, 2010
Shares Outstanding8.37M
Float6.59M
Company Overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.

The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.

It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.

It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Leadership

Andrea M. Walsh

President and Chief Executive Officer

Gregory J. Fluet

Chief Operating Officer

James L. Cunniff

President, Chief Executive Officer & Director

Joseph L. Galatowitsch

Director

Employees

177

Country

US

Sector

Healthcare

Website

smartvest.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$48.50+81.9%
Low $47High $50
Ratings Distribution
BUY
5
HOLD
0
SELL
0
TOTAL5
Insider Trades
InsiderTypeShares
Nagel Bradley M. profile photoNagel Bradley M.Grant/Award9.6K
Nagel Bradley M. profile photoNagel Bradley M.Grant/Award4.9K
Cunniff James L. profile photoCunniff James L.Automatic Sell2.7K
Nagel Bradley M. profile photoNagel Bradley M.Automatic Sell1.1K
Nagel Bradley M. profile photoNagel Bradley M.Automatic Sell674
Cunniff James L. profile photoCunniff James L.Option Exercise9.7K
Shareholders
56.5%
Institutional
(130)
3.3%
Insiderⓘ
(7)
13.1%
5%+ Owners
(4)
27.1%
Unattributed (incl. retail)ⓘ
Institutional56.5%
Insider3.3%
5%+ Beneficial13.1%
Unattributed (incl. retail)27.1%
Sources: 13F, Form 4, 13D/13GO/S: 8.4M · as of 19 Aug 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$23.01$47.40
$26.66(15th percentile)
Volume
Average Daily Volume65.98K
34.76K today vs 65.98K avg(-47%)

30d Avg

65.98K

60d Avg

84.72K

90d Avg

85.65K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...